Fairmount Funds Management LLC

Holdings History for Kiniksa Pharmaceuticals International, plc - CLASS A COMMON STOCK (KNSA)

Symbol: KNSA on Nasdaq
Investment type: Equity / CLASS A COMMON STOCK
Latest Disclosed Shares Owned: 0 shares
Security Ownership %: 0%

Shares, Excluding Options vs Price

Value, Excluding Options

Fairmount Funds Management LLC ownership in Kiniksa Pharmaceuticals International, plc CLASS A COMMON STOCK (KNSA)

14 Feb 2025 - Fairmount Funds Management LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Kiniksa Pharmaceuticals International, plc CLASS A COMMON STOCK (KNSA). This represents 0% ownership of the company. This is the first filing by Fairmount Funds Management LLC disclosing ownership of Kiniksa Pharmaceuticals International, plc CLASS A COMMON STOCK (KNSA).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Fairmount Funds Management LLC	0%		$0	0			$21.37	13G/A	31 Dec 2024	14 Feb 2025, 15:45

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	4.1%	-1.4%	$54,437,130	1,319,688	-453,151	-26%	$41.25	Q4 2025
30 Sep 2025	6.2%	0%	$68,839,338	1,772,839	0		$38.83	Q3 2025
30 Jun 2025	6.4%	+2.4%	$49,054,455	1,772,839	+670,591	+61%	$27.67	Q2 2025
31 Mar 2025	3.8%	-3.8%	$24,480,928	1,102,248	-1,092,093		$22.21	Q1 2025
31 Dec 2024	4.3%	-2%	$43,404,065	2,194,341	-1,010,500	-32%	$19.78	Q4 2024
30 Sep 2024	6.5%	0%	$80,088,977	3,204,841	0		$24.99	Q3 2024
30 Jun 2024	6.8%	+6.5%	$59,834,381	3,204,841	+3,204,841	NEW	$18.67	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.